key: cord-0700498-jevfvvx7 authors: Cui, Li-yan; Cheng, Wen-wen; Mou, Zhi-wei; Xiao, Duan; Li, Yun-yi; Li, Yu-jie; Li, Wan-ting; Chen, Zhuo-ming title: Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis date: 2021-08-18 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.08.017 sha: c18e745cab4be15afa795d00726c7063e35015c8 doc_id: 700498 cord_uid: jevfvvx7 PURPOSE: To detect the risk factors for pulmonary embolism (PE) in patients with COVID-19. METHODS: We searched for studies in PubMed, Cochrane Library, Web of Science, and EMBASE. Two authors independently screened articles and extracted data. The data were pooled by meta-analysis, and three subgroup analyses were performed. RESULTS: Of the 2210 articles identified, 27 studies were included. Pooled analysis suggested that males (odds ratio (OR) 1.49, 95% confidence interval (CI) 1.26−1.75, P = 0.000), obesity (OR 1.37, 95% CI 1.03−1.82, P = 0.033), mechanical ventilation (MV) (OR 3.34, 95% CI 1.90−5.86, P = 0.000), severe parenchymal abnormalities (OR 1.92, 95% CI 1.43−2.58, P = 0.000), ICU admission (OR 2.44, 95% CI 1.48−4.03, P = 0.000), and elevated D-dimer and white blood cell (WBC) values (at two points in time: hospital admission or closet to computer tomography pulmonary angiography (CTPA)) (P = 0.000) were correlated with a risk for PE occurrence in COVID-19 patients. However, the age and common comorbidities had no association with PE occurrence. The CTPA, unclear-ratio/low-ratio, and hospitalization subgroups had consistent risk factors with the whole studies. However, other subgroups got fewer PE risk factors. CONCLUSIONS: PE risk factors in COVID-19 are different from the classic PE risk factors. And they were likely to differ in diverse study populations. with a risk for PE occurrence in COVID-19 patients. However, the age and common 48 comorbidities had no association with PE occurrence. The CTPA subgroup had the 49 same risk factors as the whole studies, while the COVID-19 subgroup did not. The prophylaxis anticoagulation is recommended for COVID-19 patients at risk for PE. 58 And they were likely to differ in diverse study populations. Study selection and quality assessment Figure 2C3B ) The data pooled from Pulmonary vascular endothelialitis, 433 thrombosis, and angiogenesis in COVID-19 Prevalence of pulmonary 436 embolism in patients with COVID-19 pneumonia and high D-dimer values: A 437 prospective study Pulmonary embolism in patients with 440 COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter 441 study Systematic assessment of venous 444 thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence 445 and role of D-dimer as predictive factors Occurrence of acute pulmonary 448 embolism in COVID-19-a case series Pulmonary thrombosis or embolism in a large 451 cohort of hospitalized patients with COVID-19 Thrombosis in hospitalized patients with COVID-19 in a New York city health system Pulmonary embolism in patients with 457 COVID-19 pneumonia. The European respiratory journal 2020 The emerging spectrum of cardiopulmonary 460 pathology of the coronavirus disease Texas, and review of autopsy findings from other United States cities Pandemic 464 H1N1 influenza infection and vascular thrombosis Clinical prediction rules for pulmonary 467 embolism: a systematic review and meta-analysis Characteristics of acute pulmonary embolism in 470 patients with COVID-19 associated pneumonia from the city of Wuhan. Clinical and 471 applied thrombosis Venous Thromboembolism among 474 hospitalized patients with COVID-19 undergoing thromboprophylaxis: a systematic 475 27 review and meta-analysis D-dimer cut-off points and risk of venous 478 thromboembolism in adult hospitalized patients with COVID-19 COVID-19 and its implications for thrombosis and 481 anticoagulation Pulmonary embolism or thrombosis in ARDS 483 COVID-19 patients: A French monocenter retrospective study Recommendations for examining 486 and interpreting funnel plot asymmetry in meta-analyses of randomised controlled 487 trials Extent of pulmonary thromboembolic disease in 489 patients with COVID-19 on CT: relationship with pulmonary parenchymal disease Pulmonary embolism in COVID-19 patients: 492 a French multicentre cohort study Prophylactic anticoagulants for 495 people hospitalised with COVID-19 Pulmonary and cardiac pathology in African American patients with COVID-19: an 499 autopsy series from New Orleans Acute pulmonary embolism in 502 non-hospitalized COVID-19 patients referred to CTPA by emergency department COVID-19 pneumonia detected with pulmonary CT angiography Extrapulmonary manifestations of COVID-19 Management of thrombotic complications in 510 COVID-19: an update Role of upfront CT pulmonary angiography 513 at admission in COVID-19 patients Prevalence of pulmonary embolism in 516 patients at the Time of Hospital Admission for COVID-19 Clinical findings, risk factors, and final departments Measuring inconsistency in 523 meta-analyses Pulmonary embolism Adaptive immune cells temper initial innate responses Wells acore to predict pulmonary embolism in 529 patients with coronavirus disease 2019 The Task Force for the diagnosis and 534 management of acute pulmonary embolism of the European Society of Cardiology 535 (ESC). The European respiratory journal Guidance for anticoagulation management in 538 venous thromboembolism during the coronavirus disease 2019 pandemic in Poland an 539 expert opinion of the section on pulmonary circulation of the polish cardiac society Incidence of venous and arterial thromboembolic 542 complications in COVID-19: A systematic review and meta-analysis Pulmonary arterial thrombosis in COVID-19 with 545 fatal outcome: results from a prospective, single-center Acute pulmonary embolism in patients with 548 COVID-19 at CT angiography and relationship to d-dimer levels Incidence and mortality of 551 pulmonary embolism in COVID-19: a systematic review and meta-analysis High incidence of venous thromboembolic 554 events in anticoagulated severe COVID-19 patients Incidence of pulmonary 557 embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging 558 diagnosis Elevated D-dimers and lack of anticoagulation 561 predict PE in severe COVID-19 patients Pulmonary artery thrombi are 564 co-located with opacifications in SARS-CoV2 induced ARDS Pulmonary 567 embolism during the COVID-19 pandemic: Decline in diagnostic procedures and 568 incidence at a university hospital Pulmonary thromboembolic disease in COVID-19 571 patients on CT pulmonary angiography-Prevalence, pattern of disease and 572 relationship to D-dimer Lung pathology in COVID-19: A systematic review Prevalence and characteristics of pulmonary 578 embolism in 1042 COVID-19 patients with respiratory symptoms: A nested 579 case-control study Pulmonary embolism in patients 582 with covid-19 pneumonia: the utility of d-dimer Acute pulmonary embolism and COVID-19 Estimating the burden of SARS-CoV-2 in France The pooled prevalence of pulmonary 592 embolism in patients with COVID-19 Factors associated with pulmonary 595 embolism among coronavirus disease 2019 acute respiratory distress syndrome: a 596 multicenter study among 375 patients Pulmonary embolism among critically 599 ill patients with ARDS due to COVID-19 SARS-CoV-2 entry factors are highly 602 expressed in nasal epithelial cells together with innate immune genes Higher intensity thromboprophylaxis 605 regimens and pulmonary embolism in critically ill coronavirus disease 2019 patients. 606 Critical care medicine 2020 Clinical and computed tomography 609 characteristics of COVID-19 associated acute pulmonary embolism: A different 610 phenotype of thrombotic disease? Endothelial cell infection and endotheliitis in 613 COVID-19 A higher D-dimer threshold 616 for predicting pulmonary embolism in patients with COVID-19: a retrospective study Increased incidence of acute pulmonary 619 embolism in emergency department patients during the COVID-19 pandemic Pulmonary embolism in 622 hospitalised patients with COVID-19 Worldometer COVID-19 Data, Available at Venous thromboembolic events in patients with 627 COVID-19: A systematic review and meta-analysis The methodological quality assessment tools for 630 preclinical and clinical studies, systematic review and meta-analysis, and clinical 631 practice guideline: a systematic review Risk factors of critical & mortal COVID-19 cases: A 634 systematic literature review and meta-analysis Combining lung ultrasound and Wells 637 score for diagnosing pulmonary embolism in critically ill COVID-19 patients